ABUS

Arbutus Biopharma
$4.32
+$0.03 (+0.7%)Oct 28, 2026
6.4GoodMoatMint rating

MoatMint rates Arbutus Biopharma (ABUS) 6.4 out of 10, a research rating of the company's quality, value, growth, momentum and financial health. Its quality rating is 2.9 out of 10.

Return+11.3%5YRange $1.73 - $5.22
$5.6$4.2$2.8$1.3Nov 21Sep 25Oct 26

Key metrics

The numbers that frame ABUS today
Market cap
$854.70M
P/E (TTM)
5.5
Gross margin
100%
EV / Sales
4.6
ROIC
93.2%
Div yield
0%
Debt / equity
0.0
52wk Low
$3.50
52wk High
$5.45

ABUS stock rating

How ABUS scores on quality, value, growth, momentum and financial health
6.4out of 10
Good overallFair business, fair price
Quality2.9
Growth5.6
Momentum7.3
Value6.5
Financial Health9.4

Growth

Revenue and earnings trend for ABUS
RevenueNet income
See the full growth breakdown

Revenue and earnings trends, margins and the multi-year trajectory - free with an account.

Create a free account
Free foreverNo card required
Already a member? Log in

Cash flow & returns

Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture

Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.

Create a free account
Free foreverNo card required
Already a member? Log in

Insider trading

Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade

See who is buying and selling, how much, and when - updated as new filings land.

Create a free account
Free foreverNo card required
Already a member? Log in

Frequently asked questions

Plain-English answers about ABUS
Is Arbutus Biopharma a good buy?
Hold. Arbutus Biopharma has strong momentum, but poor quality makes the setup mixed. Growth looks mixed. The support signal is useful, but not decisive. We think Arbutus Biopharma is selling at a fair price.
What is the market capitalization of ABUS?
Arbutus Biopharma's market capitalization is $854.70M.
What is the P/E (TTM) ratio for ABUS stock?
Arbutus Biopharma's P/E (TTM) ratio is 5.5, based on trailing earnings.
What is the 52-week high for ABUS stock?
The 52-week high for Arbutus Biopharma is $5.45. The current close of $4.32 is 20.7% below that high.
What is the 52-week low for ABUS stock?
The 52-week low for Arbutus Biopharma is $3.50. The current close of $4.32 is 23.4% above that low.
Does ABUS stock pay dividends?
Arbutus Biopharma does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for ABUS?
Arbutus Biopharma's Debt / Equity ratio is 0.01.